Vir Biotechnology Inc.
VIR
|
|
| |
|
| Trading Volume | 24,611 |
|
|
12.66 - 7.76 |
| Market Cap Full | $ 1.1B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 2.3% | 0.7% | -8.1% | -38.6% |
| Q2 | - | -13% | 5.4% | -1.7% |
| Q3 | - | -18.4% | -61.8% | -24.3% |
| Q4 | - | -27.8% | 11.9% | 31.3% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.3 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -6.6 | 19.6 | -9.9 | -21.3 | 28.7 | -13.5 | 14.6 | -18.4 | - | - | - | -6.7 |
| 2023 | |||||||||||
| 16.8 | -22.8 | 2.1 | 8.1 | 6 | -8 | -42.6 | -10.1 | -26 | -15.4 | 19.7 | 6 |
| 2022 | |||||||||||
| -18.7 | -26.6 | 2.9 | -15.9 | 18.4 | -1.3 | 9.2 | -14.6 | -18.8 | 14 | 28.4 | -10.3 |
| 2021 | |||||||||||
| 141 | -4.5 | -16.8 | -6.9 | -12.2 | 12.8 | -24.6 | 44.6 | -13.1 | -14.5 | 23.8 | -11 |
| 2020 | |||||||||||
| 94.9 | 76.9 | -23 | -11 | 12 | 19.9 | 16.6 | -15.2 | -15.2 | -9.3 | 2.4 | -16 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -1.1 | 3.9 | -1.3 | 0 |
| Q2 | -1.5 | -0.6 | 0.5 | 0 |
| Q3 | -1.2 | 1.3 | 0.8 | 0 |
| Q4 | 0 | -0.7 | 4 | 0 |
| A | -3.73 | 3.8 | 4 | -2.5 |